首页 | 本学科首页   官方微博 | 高级检索  
     

脑心通胶囊治疗椎基底动脉缺血性眩晕的疗效分析
引用本文:宋承伟,方明,叶金华,蔡谋善,黄肖群. 脑心通胶囊治疗椎基底动脉缺血性眩晕的疗效分析[J]. 中国实用医药, 2007, 2(26): 20-21
作者姓名:宋承伟  方明  叶金华  蔡谋善  黄肖群
作者单位:湖北省宜昌市第一人民医院神经内科,443000
摘    要:目的探讨脑心通胶囊治疗椎基底动脉缺血性眩晕的临床疗效。方法将120例患者随机分为治疗组60例,对照组60例,观察比较治疗前后症状、TCD、血液流变学、血脂变化。结果脑心通胶囊治疗组在症状、TCD、血液流变学与对照组间差异有统计学意义,在血脂方面变化不大,同时未发现有明显不良反应。结论脑心通胶囊治疗椎基底动脉缺血性眩晕(VBAIV)疗效显著,安全性良好。

关 键 词:脑心通胶囊  椎基底动脉缺血性眩晕

Observating effect of clinical treatment in naoxintong capsule to treat the vertebrat - basilar artery ischemia vertigo
SONG Cheng-wei,FANG Ming,YE Jin-hua,et al.. Observating effect of clinical treatment in naoxintong capsule to treat the vertebrat - basilar artery ischemia vertigo[J]. China Practical Medical, 2007, 2(26): 20-21
Authors:SONG Cheng-wei  FANG Ming  YE Jin-hua  et al.
Affiliation:SONG Cheng-wei,FANG Ming,YE Jin-hua,et al.Department of Neurology,the Firse Hospital of Yichang,Yichang 443000,China
Abstract:Objective To investigate the effect of clinical treatment in naoxintong capsule to treat the vertebral-basilar artery ischemia vertigo(VBAIV).Methods 120 patients who suffered from VBAIV were randomly divided into the treatment group(60 cases) and the control group(60 cases),we Studied the difference of the syndrome,TCD,hemodynamic change,blood-fat before and affer treatment.Results The effective rate in the treatment group was significantly higher than the control group on the syndrome,TCD,hemodynamic change,before and after treatment,but blood-fat no changes.No obvious side-effect was found in the treatment group.Conclusion Naoxintong capsuie is safe and effective to treat VBAIV.
Keywords:Naoxintong capsuie  Vertebral-basilar artery ischemia vertigo(VBAIV)
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号